Myelofibrosis patients in Scotland get access to Inrebic (Fedratinib) on the NHS
We have some important and very welcome news to share with you about a new drug for myelofibrosis patients. After a long and complicated appraisal process, the Scottish Medicines Association (SMC) has decided that fedratinib is to be made available to NHS Scotland. The drug, to be distributed under the name Inrebic, is the first…